Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Prognostic Factors in Patients With Early-stage Invasive Lobular Breast Carcinoma (ILC) With AI - Assisted Pathology

NCT07842055 is registered in ClinicalTrials.gov with Hellenic Cooperative Oncology Group as lead sponsor.

NCT NCT07842055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07842055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Prognostic Factors in Patients With Early-stage Invasive Lobular Breast Carcinoma (ILC) With AI - Assisted Pathology
Lead sponsor
Hellenic Cooperative Oncology Group
Phase
Observational
Overall status
Completed
Start date
December 10, 1996
Completion date
July 13, 2026
Enrollment
3,648 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early-stage invasive lobular breast carcinoma